Table 1.
Oligonucleotides used in this studya
Name | Sequence |
---|---|
JMS bglGf | CTGCTGGCGGGGAAAGATAGCGACAAATAATTCACC |
JMS bglGr | CGCGTTTTTGAAAGCCAATTCCGCGCCCCAT |
blgG RT 5′ | ACTGGCAATGGTCAGTTAGCGAGA |
blgG RT 3′ | TTCCTCTTGAGGTGATGGCAACCT |
gyrB RT 5′ | CACTTTCACGGAAACGACCGCAAT |
gyrB RT 3′ | TTACCAACAACATTCCGCAGCGTG |
proV RT 5′ | AATATTTGGCGAGCATCCACAGCG |
proV RT 3′ | TTTACCCGAGCCGGATAATCCCAT |
SSA1 | AAAACATATGAGCGAAGCACTTAAAATTCTGAACAACATCC |
SSA2 | AAAACTCGAGTTCCTTGATCAGGAAATCTTCCAGTTGCTTACC |
SSA4 | AAAACTCGAGAGCGCTTTCTTCTTCACGACGCTCATTAACG |
SSA5 | AAAACTCGAGCATTTCACGATACTGTTGCAGTTTACGAGTGCG |
SSA6 | AAAACATATGCAGTATCGTGAAATGTTAATTGCCGACGGCA |
SSA7 | AAAACATATGGCAGCTCGTCCGGCTAAATATAGCTATGTT |
SSA24 | AAAACCATGGCTATGACAAAGAAATTTAAAGTGTCCTTCGACG |
SSA26 | AAAACCATGGCTATCACTAAGAAATTTAAAGTGTCCTTTGATGTTACC |
SSA27 | AAAACTCGAGAAGCAGTAATTTCCCAAGCGCCAC |
SSA30A | GGCAATCTTAGAGAAAGATATGCCGCATCTATGTAAGCAGGTCGG |
SSA30B | CCGACCTGCTTACATAGATGCGGCATATCTTTCTCTAAGATTGCC |
SSA105 | AAAACTCGAGAGCCATGCTATTCAGCAGTTCATTCGGGT |
SSA141 | AAAACTCGAGTCAGAACACCTCCCGTACTGTTGC |
SSA151 | AAAACCATGGGTATTAACAAACAGTTTCGCG |
SSA152 | AAAACTCGAGTCACTTAGTCACCCTCACGGTTG |
SSA153 | AAAACATGTCTAAGATGACCGTTAACGTAAAAG |
SSA154 | TTTTCTCGAGTTAGCGGAACGTTACCAGAGCC |
SSA158 | AAAACTCGAGTCATTTGAACACCTCTCGCACAGT |
SSA159 | AAAACCATGGCTATTACTAAACGTTTTAAAGTATCATTC |
SSA160 | AAAACTCGAGTTACTTCACCTCACGAATAGTTGCTGG |
SSA162 | AAAACCATGGCTATTACTAAACGTTTTAAAGTATCATTTG |
SSA163 | AAAACTCGAGTTACTTCACCTCACGGATAGTTGCTG |
SSA165 | AAAACACCCATGGCAATGACCAAACAC |
Sequences are oriented from 5′ to 3′. Restriction sites are underlined.